查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
歐洲單細胞多組體學市場－分析與預測（2023-2033）
市場調查報告書
商品編碼
1416206

歐洲單細胞多組體學市場－分析與預測（2023-2033）

Europe Single-Cell Multi-Omics Market: Analysis and Forecast, 2023-2033
出版日期: | 出版商: BIS Research | 英文 89 Pages | 商品交期: 1-5個工作天內

價格
主要市場統計數據
預測期 2023-2033
2023年評估 3.5億美元
2033年預測 17.1億美元
複合年成長率 17.23%

2023年歐洲單細胞多組體學市場規模將達3.5億美元。

預計到 2033 年，市場規模將達到 17.1 億美元，2023-2033 年預測期間複合年成長率為 17.23%。該市場的普及、在疾病篩檢和診斷中使用單細胞多組體學方法向個人化醫療的轉變以及向單細胞測序的轉變。細胞多組體學在藥物開發中的應用。這種成長是由多種因素推動的，包括更多地採用

由於基因組研究的進步和個體化醫療保健的日益普及，歐洲單細胞多組體學市場正在經歷顯著成長。研究人員正在利用單細胞多體學技術來更深入地了解疾病的分子機制，以實現更準確的診斷和治療。此外，這些技術透過實現高度針對性的治療方法正在徹底改變藥物開發。歐洲憑藉其強大的醫療基礎設施和研究能力，處於單細胞多體學實施的最前線。學術機構、生技公司和醫療保健營業單位之間的合作正在推動創新，擴大這些最尖端科技的應用範圍，並幫助擴大市場。

本報告考察了歐洲單細胞多組體學市場，並提供了市場概述，包括行業前景、COVID-19 影響、區域趨勢以及參與市場的公司概況。

目錄

執行摘要

調查範圍

調查方法

第1章 市場

  • 全球市場展望
  • 市場概況
  • 產業展望
    • 法律規範
    • 專利分析
    • 主要趨勢
    • 機會評估
    • 產品基準評效
    • 臨床試驗
  • COVID-19 的影響
  • 業務動態
    • 影響分析
    • 業務驅動力
    • 業務抑制因素
    • 商業機遇

第2章 歐洲

  • 歐洲
    • 主要發現和機會評估
    • 市場動態
    • 市場規模及預測

第3章市場－競爭基準化分析與公司概況

  • 競爭基準化分析
    • 關鍵策略和發展
    • 市場佔有率分析
    • 成長佔有率分析
    • 企業視覺圖形
    • 活躍於多組體學生態系統的公司
  • 公司簡介
    • Menarini Group
    • QIAGEN NV
    • Rarecells Diagnostics
    • Scipio Bioscience
    • Singleron Biotechnologies
Product Code: BHP1812SS

“The Europe Single-Cell Multi-Omics Market Expected to Reach $1.71 Billion by 2033.”

Introduction to Europe Single-Cell Multi-Omics Market

KEY MARKET STATISTICS
Forecast Period2023 - 2033
2023 Evaluation$0.35 Billion
2033 Forecast$1.71 Billion
CAGR17.23%

The Europe single-cell multi-omics market was valued at $0.35 billion in 2023 and is expected to reach $1.71 billion by 2033, growing at a CAGR of 17.23% during the forecast period 2023-2033. The market experiences growth due to several factors, including the increasing prevalence of large-scale genomics studies utilizing single-cell RNA sequencing (Sc-RNA), a shift towards personalized medicine using the single-cell multi-omics approach in disease screening and diagnostics, and the rising adoption of single-cell multi-omics in drug development.

Market Introduction

The Europe Single-Cell Multi-Omics Market is experiencing significant growth due to the advancements in genomics research and the increasing adoption of personalized healthcare. Researchers are leveraging single-cell multi-omics technologies to gain deeper insights into the molecular mechanisms of diseases, resulting in more precise diagnostics and treatments. Furthermore, these technologies are revolutionizing drug development by enabling highly targeted therapeutic approaches. Europe, with its robust healthcare infrastructure and research capabilities, is at the forefront of embracing single-cell multi-omics. Collaborations among academic institutions, biotech companies, and healthcare entities are driving innovation and expanding the scope of applications for these cutting-edge technologies, contributing to the market's expansion.

Market Segmentation:

Segmentation 1: by Country

  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest-of-Europe

How can this report add value to an organization?

Growth/Marketing Strategy: The Europe single-cell multi-omics market has seen major development by key players operating in the market, such as new offerings, partnerships, collaboration, and joint ventures.

Competitive Strategy: The Europe single-cell multi-omics market has witnessed growth in recent years; as the field of single-cell multi-omics grows, it has witnessed increased collaboration between researchers, academic institutions, and industry partners to drive innovation and commercialization of these technologies. Single-cell multi-omics technologies are already being used in various applications, such as cancer research, immunology, and neuroscience. As the technologies continue to improve, they may be applied to other areas of research, such as developmental biology and stem cell research.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and regional presence.

Some of the prominent names in this market are:

  • Menarini Group
  • QIAGEN NV
  • Rarecells Diagnostics
  • Scipio Bioscience
  • Singleron Biotechnologies

Table of Contents

Executive Summary

Scope of the Study

Research Methodology

1. Market

  • 1.1. Global Market Outlook
    • 1.1.1. Product Definition
    • 1.1.2. Inclusion and Exclusion Criteria
  • 1.2. Market Overview
    • 1.2.1. Key Findings
    • 1.2.2. Current Market Scenario
      • 1.2.2.1. For Researchers
      • 1.2.2.2. For Diagnostics
  • 1.3. Industry Outlook
    • 1.3.1. Regulatory Framework
    • 1.3.2. Patent Analysis
      • 1.3.2.1. Awaited Technological Developments
      • 1.3.2.2. Patent Filing Trend (by Country)
      • 1.3.2.3. Patent Filing Trend (by Year)
    • 1.3.3. Key Trends
      • 1.3.3.1. Advancements in Imaging Techniques for Single-Cell Sequencing
      • 1.3.3.2. Use of Artificial Intelligence (AI) and Machine Learning (ML) in Single-Cell Multi-Omics
      • 1.3.3.3. Increased Development of Advanced Solution Based on Single-Cell Technology
    • 1.3.4. Opportunity Assessment
    • 1.3.5. Product Benchmarking
    • 1.3.6. Clinical Trials
  • 1.4. COVID-19 Impact
    • 1.4.1. Pre-COVID-19
    • 1.4.2. During COVID-19
    • 1.4.3. Post COVID-19
  • 1.5. Business Dynamics
    • 1.5.1. Impact Analysis
    • 1.5.2. Business Drivers
      • 1.5.2.1. Rising Number of Large-Scale Genomics Studies Leveraging Single-Cell RNA Sequencing (Sc-RNA)
      • 1.5.2.2. Use of Single-Cell Multi-Omics Approach for Screening and Diagnostics of Diseases Leading to Shift Toward Personalized Medicine
      • 1.5.2.3. Increasing Use of Single-Cell Multi-Omics for Drug Development
      • 1.5.2.4. Collaborations among Technology Providers and Life Sciences Companies for Accelerating the Research in Single-Cell Multi-Omics
    • 1.5.3. Business Restraints
      • 1.5.3.1. High Cost of Single-Cell Analysis and Sequencing
      • 1.5.3.2. Limited Availability of Large Online Data Storage and Analysis Platforms
    • 1.5.4. Business Opportunities
      • 1.5.4.1. Expansion into New Research Applications, Such as Single-Cell Metabolomics
      • 1.5.4.2. Increasing Adoption of Genomic-Based Medicine in Emerging Nations

2. Europe

  • 2.1. Europe
    • 2.1.1. Key Findings and Opportunity Assessment
    • 2.1.2. Market Dynamics
      • 2.1.2.1. Impact Analysis
    • 2.1.3. Market Sizing and Forecast
      • 2.1.3.1. Europe Single-Cell Multi-Omics Market (by Country)
        • 2.1.3.1.1. Germany
        • 2.1.3.1.2. Italy
        • 2.1.3.1.3. U.K.
        • 2.1.3.1.4. Spain
        • 2.1.3.1.5. France
        • 2.1.3.1.6. Rest-of-Europe

3. Markets - Competitive Benchmarking & Company Profiles

  • 3.1. Competitive Benchmarking
    • 3.1.1. Key Strategies and Developments
      • 3.1.1.1. Funding Activities
      • 3.1.1.2. New Offerings
      • 3.1.1.3. Mergers and Acquisitions
      • 3.1.1.4. Partnership, Collaboration, and Business Expansion
    • 3.1.2. Market Share Analysis
    • 3.1.3. Growth Share Analysis
      • 3.1.3.1. By Application
      • 3.1.3.2. By Omics Type
      • 3.1.3.3. By Product Type
    • 3.1.4. Visual Graphics of the Companies
    • 3.1.5. Multi-Omics Ecosystem Active Players
  • 3.2. Company Profiles
    • 3.2.1. Menarini Group
      • 3.2.1.1. Company Overview
      • 3.2.1.2. Role of Menarini Group in the Single-Cell Multi-Omics Market
      • 3.2.1.3. Analyst Perspective
    • 3.2.2. QIAGEN NV
      • 3.2.2.1. Company Overview
      • 3.2.2.2. Role of QIAGEN NV in the Single-Cell Multi-Omics Market
      • 3.2.2.3. Financials
      • 3.2.2.4. Analyst Perspective
    • 3.2.3. Rarecells Diagnostics
      • 3.2.3.1. Company Overview
      • 3.2.3.2. Role of Rarecells Diagnostics in the Single-Cell Multi-Omics Market
      • 3.2.3.3. Analyst Perspective
    • 3.2.4. Scipio Bioscience
      • 3.2.4.1. Company Overview
      • 3.2.4.2. Role of Scipio Bioscience in the Single-Cell Multi-Omics Market
      • 3.2.4.3. Analyst Perspective
    • 3.2.5. Singleron Biotechnologies
      • 3.2.5.1. Company Overview
      • 3.2.5.2. Role of Singleron Biotechnologies in the Single-Cell Multi-Omics Market
      • 3.2.5.3. Recent Developments
      • 3.2.5.4. Analyst Perspective

List of Figures

  • Figure 1: An Overview of Single-Cell Multi-Omics Sequencing Technologies
  • Figure 2: Single-Cell Multi-Omics Market, Impact Analysis
  • Figure 3: Single-Cell Multi-Omics Market (by Region), $Billion, 2022 and 2033
  • Figure 4: Single-Cell Multi-Omics Market: Research Methodology
  • Figure 5: Primary Research Methodology
  • Figure 6: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 7: Top-Down Approach (Segment-Wise Analysis)
  • Figure 8: Single-Cell Multi-Omics Market, Patent Analysis (by Country), January 2018- March 2023
  • Figure 9: Single-Cell Multi-Omics Market, Patent Analysis (by Year), January 2018-December2022
  • Figure 10: Single-Cell Multi-Omics Market, Key Trends, Market Shift, 2022-2033
  • Figure 11: Single-Cell Multi-Omics Market, Impact Analysis
  • Figure 12: Global Data for Rare Diseases, 2020
  • Figure 13: Companies Using Multi-Omics Approach in Research and Development of Drugs and Vaccines
  • Figure 14: Advantages of Multi-Omics in Drug Discovery and Development
  • Figure 15: Cost of Single Cell Sequencing (by Company)
  • Figure 16: Some of the Advancements in Single-Cell Metabolomics
  • Figure 17: Single-Cell Multi-Omics Market Share (by Region)
  • Figure 18: Europe Single-Cell Multi-Omics Market, Incremental Opportunity (by Country), $Million, 2023-2033
  • Figure 19: Europe Single-Cell Multi-Omics Market, $Billion, 2022-2033
  • Figure 20: Europe Single-Cell Multi-Omics Market (by Country), % Share, 2022 and 2033
  • Figure 21: Germany Single-Cell Multi-Omics Market, $Million, 2022-2033
  • Figure 22: Italy Single-Cell Multi-Omics Market, $Million, 2022-2033
  • Figure 23: U.K. Single-Cell Multi-Omics Market, $Million, 2022-2033
  • Figure 24: Spain Single-Cell Multi-Omics Market, $Million, 2022-2033
  • Figure 25: France Single-Cell Multi-Omics Market, $Million, 2022-2033
  • Figure 26: Rest-of-Europe Single-Cell Multi-Omics Market, $Million, 2022-2033
  • Figure 27: Single-Cell Multi-Omics Market, Number of Key Developments and Strategies, January 2018-March 2023
  • Figure 28: Funding Activities, January 2018-March 2023
  • Figure 29: New Offerings, January 2018-March 2023
  • Figure 30: Mergers and Acquisitions, January 2018-March 2023
  • Figure 31: Partnership, Collaboration, and Business expansion, January 2018-March 2023
  • Figure 32: Single-Cell Multi-Omics Market, Company Revenue Share Analysis, $Billion, 2022
  • Figure 33: Single-Cell Multi-Omics Market, Growth-Share Matrix (by Application), 2023-2033
  • Figure 34: Single-Cell Multi-Omics Market, Growth-Share Matrix (by Omics Type), 2023-2033
  • Figure 35: Single-Cell Multi-Omics Market, Growth-Share Matrix (by Product Type), 2023-2033
  • Figure 36: Single Cell Multi Omics Market, Visual Graphics of the Companies
  • Figure 37: Menarini Silicon Biosystems: Product Portfolio
  • Figure 38: QIAGEN NV: Product Portfolio
  • Figure 39: QIAGEN NV: Overall Financials, $Million, 2020-2022
  • Figure 40: QIAGEN NV: Net Revenue (by Segment), $Million, 2020-2022
  • Figure 41: QIAGEN NV: Net Revenue (by Region), $Million, 2020-2022
  • Figure 42: QIAGEN NV: R&D Expenditure, $Million, 2020-2020
  • Figure 43: Rarecells Diagnostics: Product Portfolio
  • Figure 44: Scipio Bioscience: Product Portfolio
  • Figure 45: Singleron Biotechnologies: Product Portfolio

List of Tables

  • Table 1: Single-Cell Multi-Omics Market, Key Developments Analysis, January 2018-March 2023
  • Table 2: Key Questions Answered in the Report
  • Table 3: Single-Cell Multi-Omics Market: Global Regulatory Organization
  • Table 4: Single-Cell Multi-Omics Market, Product Benchmarking
  • Table 5: Single-Cell Multi-Omics Market, Ongoing Clinical Trials
  • Table 6: Single-Cell Multi-Omics Platforms Used in the Diagnosis of Disease
  • Table 7: Recent Collaborations between Technology Providers and Life Sciences Companies
  • Table 8: Europe Single-Cell Multi-Omics Market Dynamics, Impact Analysis
  • Table 9: Multi-Omics Ecosystem Active Players